Internal Medicine, Nephrology · Seattle, WA
NPI
1043423775
Since 2007
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1100 9th Ave
Seattle, WA, 98101
Phone (202) 223-6673
Groups this clinician bills Medicare through
Medicare paid, 2024
$121K
2,833 services
Medicare patients, 2024
403
Average age 71
Drug cost, 2024
$338K
2,373 prescriptions
Company payments, 2023
$3.08
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahmad Mahallati-Shirazi was code 36415 (venipuncture blood collection), 346 times for 137 patients. In total Ahmad Mahallati-Shirazi billed 2,833 services in 40 codes, and Medicare paid $121K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-06-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 346 | 137 | $8.65 | $2,993 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 228 | 110 | $13.07 | $2,981 |
| 99233 Hospital E&M - Subsequent | Facility | 193 | 74 | $97.24 | $19K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 166 | 96 | $13.21 | $2,192 |
| 99215 Office E&M - Established | Office | 152 | 82 | $143.51 | $22K |
| 99215 Office E&M - Established | Facility | 147 | 95 | $112.94 | $17K |
| 90935 Hemodialysis | Facility | 131 | 52 | $58.43 | $7,655 |
| 99214 Office E&M - Established | Office | 95 | 79 | $101.55 | $9,648 |
| 99214 Office E&M - Established | Facility | 53 | 43 | $73.74 | $3,908 |
| 99223 Hospital E&M - Initial | Facility | 49 | 49 | $139.24 | $6,823 |
| 99232 Hospital E&M - Subsequent | Facility | 45 | 32 | $64.47 | $2,901 |
| 81003 Clinical Chemistry | Office | 37 | 34 | $2.20 | $81.4 |
| 99222 Hospital E&M - Initial | Facility | 29 | 27 | $102.53 | $2,973 |
| 99205 Office E&M - New | Office | 29 | 29 | $159.63 | $4,629 |
| 99205 Office E&M - New | Facility | 19 | 19 | $120.21 | $2,284 |
By year: 2022 $116K for 2,028 services; 2023 $123K for 1,697 services; 2024 $121K for 2,833 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 346 | 137 | $8.65 | $2,993 |
| 81003 Clinical Chemistry | 37 | 34 | $2.20 | $81.4 |
| 81001 Clinical Chemistry | 19 | 15 | $3.11 | $59.09 |
Medicare prescription drug claims, 2024
In 2024, the drug Ahmad Mahallati-Shirazi prescribed most often to Medicare patients was Carvedilol, with 204 prescriptions and refills. In total Ahmad Mahallati-Shirazi wrote 2,373 Medicare prescriptions that cost $338K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carvedilol Generic | 204 | 472 | 67 | $2,593 |
| Amlodipine Besylate Generic | 189 | 515 | 63 | $1,619 |
| Furosemide Generic | 183 | 417 | 50 | $1,420 |
| Losartan Potassium Generic | 145 | 397 | 51 | $2,033 |
| Lisinopril Generic | 87 | 234 | 25 | $969 |
| Metoprolol Succinate Generic | 82 | 195 | 23 | $1,054 |
| Calcitriol Generic | 79 | 164 | 23 | $2,176 |
| Felodipine Er Felodipine | 75 | 206 | 25 | $2,241 |
| Prednisone Generic | 70 | 157 | 27 | $706 |
| Doxazosin Mesylate Generic | 57 | 123 | 16 | $971 |
| Famotidine Generic | 54 | 130 | 21 | $616 |
| Atorvastatin Calcium Generic | 50 | 127 | 16 | $532 |
| Farxiga Dapagliflozin Propanediol | 47 | 103 | 15 | $58K |
| Valsartan Generic | 46 | 117 | 21 | $1,060 |
| Chlorthalidone Generic | 42 | 121 | 14 | $961 |
Brand drugs: 191 claims; generic drugs: 2,165 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Ahmad Mahallati-Shirazi $3.08 ($3.08 in general payments such as food, travel and fees) from 1 company. The largest payer was Travere Therapeutics, Inc. with $3.08.
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. TVTX | 1 | $3.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.